![]() Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. The half-life of methemoglobin can be reduced by Methylene blue from hours to minutes. In another patient with previous episodes of ifosfamide encephalopathy, methylene-blue was administered orally prophylactically. In one patient, ifosfamide neurotoxicity was rapidly reversed by methylene-blue 50 mg intravenously. Methylene blue first transforms into leucomethylene blue when administered intravenously as an antidote, and leucomethylene blue then changes the heme group from methemoglobin to hemoglobin. We therefore used the electron-accepting drug methylene-blue as an antidote for ifosfamide encephalopathy. The standard intravenous dose is 1 to 2 mg of methylene blue per kg of body weight (0.1 to 0.2 mL/kg of a 1 solution) over 5 to 10 minutes, repeated in one hour if needed. Methylene blue is presently mainly used to treat methemoglobinemia. Rocky Mountain Regenerative Medicine makes no representation or warranty as to the reliability, accuracy, timeliness, usefulness, adequacy or suitability of the information contained in this website. Administer methylene blue antidote to patients who have cardiopulmonary symptoms. If you think you may be suffering from a medical condition, you should seek immediate medical attention. The material here, including but not limited to text, graphics, and images, is not an alternative to medical consultation, diagnosis, and/or treatment rendered by a qualified physician or healthcare provider. ![]() This website contains general information about medical conditions and possible treatments. Keywords: Acute methemoglobinemia, Atropine, Intermediate syndrome, Methylene blue, Nitrobenzene poisoning. Methylene Blue Treatment for Methemoglobinemia When doctors administer methylene blue intravenously to methemoglobinemia patients, the medicine acts as an antidote by converting methemoglobin back to hemoglobin, which restores its oxygen-carrying capacity. Methylene blue has been in medicinal use for centuries and is best known as an antidotal treatment for acquired methemoglobinemia (MetHB). THIS WEBSITE IS NOT INTENDED FOR THE PURPOSE OF PROVIDING MEDICAL ADVICE.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |